Blood Salvage System for Bypass Surgery
By HospiMedica staff writers Posted on 20 Jan 2005 |
A blood salvage system allows surgeons to recover blood lost by a patient during and after cardiovascular surgery and makes the blood available for transfusion back to the patient. The system has been cleared by the U.S. Food and Drug Administration (FDA).
Called CardioPAT, the system is designed to ensure that patients are transfused with the safest blood possible, which is their own. A device provides better functionality that makes the system ideally suited for providing autotransfusion during off-pump, or beating-heart, surgery. The system can salvage blood lost both in the operating room and during recovery in the intensive care unit. CardioPAT is the product of Haemonetics Corp. (Braintree, MA, USA), whose Cell Saver platform created and leads the surgical blood salvage market.
Haemonetics estimated that about 20% of annual coronary artery bypass graft surgeries use the off-pump surgical technique. The company is beginning customer-acceptance trials at three U.S. sites. In prior trials in Europe, the system performed very well, the company noted.
"This is a very exciting technique that will have compelling benefits for heart patients,” remarked Dr. Andrew Owens, clinical director of cardiothoracic surgery at the James Cook University Hospital (Middlesbrough, UK), who led the first trials. "The system gives patients the advantage of getting their own blood back, but also helps ensure that banked blood is available for other patients.”
Related Links:
Haemonetics
Called CardioPAT, the system is designed to ensure that patients are transfused with the safest blood possible, which is their own. A device provides better functionality that makes the system ideally suited for providing autotransfusion during off-pump, or beating-heart, surgery. The system can salvage blood lost both in the operating room and during recovery in the intensive care unit. CardioPAT is the product of Haemonetics Corp. (Braintree, MA, USA), whose Cell Saver platform created and leads the surgical blood salvage market.
Haemonetics estimated that about 20% of annual coronary artery bypass graft surgeries use the off-pump surgical technique. The company is beginning customer-acceptance trials at three U.S. sites. In prior trials in Europe, the system performed very well, the company noted.
"This is a very exciting technique that will have compelling benefits for heart patients,” remarked Dr. Andrew Owens, clinical director of cardiothoracic surgery at the James Cook University Hospital (Middlesbrough, UK), who led the first trials. "The system gives patients the advantage of getting their own blood back, but also helps ensure that banked blood is available for other patients.”
Related Links:
Haemonetics
Latest Surgical Techniques News
- AI Assisted Reading Tool for Small Bowel Video Capsule Endoscopy Detects More Lesions
- First-Ever Contact Force Pulsed Field Ablation System to Transform Treatment of Ventricular Arrhythmias
- Caterpillar Robot with Built-In Steering System Crawls Easily Through Loops and Bends
- Tiny Wraparound Electronic Implants to Revolutionize Treatment of Spinal Cord Injuries
- Small, Implantable Cardiac Pump to Help Children Awaiting Heart Transplant
- Gastrointestinal Imaging Capsule a Game-Changer in Esophagus Surveillance and Treatment
- World’s Smallest Laser Probe for Brain Procedures Facilitates Ablation of Full Range of Targets
- Artificial Intelligence Broadens Diagnostic Abilities of Conventional Coronary Angiography
- AI-Powered Surgical Visualization Tool Supports Surgeons' Visual Recognition in Real Time
- Cutting-Edge Robotic Bronchial Endoscopic System Provides Prompt Intervention during Emergencies
- Handheld Device for Fluorescence-Guided Surgery a Game Changer for Removal of High-Grade Glioma Brain Tumors
- Porous Gel Sponge Facilitates Rapid Hemostasis and Wound Healing
- Novel Rigid Endoscope System Enables Deep Tissue Imaging During Surgery
- Robotic Nerve ‘Cuffs’ Could Treat Various Neurological Conditions
- Flexible Microdisplay Visualizes Brain Activity in Real-Time To Guide Neurosurgeons
- Next-Gen Computer Assisted Vacuum Thrombectomy Technology Rapidly Removes Blood Clots